About Us
Cambrooke was founded in 2000 by Lynn and David Paolella, the parents of two children diagnosed with a rare disease called phenylketonuria (PKU). PKU is one of the few genetic diseases, which is managed almost entirely through diet. The Paolellas’ goal in forming Cambrooke was simple – to develop improved nutritional therapeutic options for those with serious medical disorders.
Today, Cambrooke produces formulas and foods for the management of a variety of medical conditions and we are continually innovating new nutritional options targeted at a wide array of diseases.
Milk-style drinks
Glytactin RTD LITE 15 Vanilla & Coffee Mocha
Glytactin RTD 15
Chocolate and Original
Mix-ins
Glytactin BUILD 10, 20 Unflavored
Bars
Glytactin Complete Bars 15 Fruit Frenzy and Peanut Butter
Glytactin for PKU
Cambrooke was the first company to use a natural whole (intact) protein to make PKU formulas – GlytactinTM (modified glycomacropeptide).
KetoVie for Intractable Epilepsy
Ketovie is a liquid ketogenic formula for intractable epilepsy and thepeutic ketogenic diets. Learn more about our product range…
